← FDA Drug Approvals (Drugs@FDA)
ESLICARBAZEPINE ACETATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AUROBINDO PHARMA LTD · Approved 2023-07-31
Drug application
- FDA Application #
ANDA216481- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- ESLICARBAZEPINE ACETATE
- Generic name
- Eslicarbazepine Acetate
- Active ingredients
- ESLICARBAZEPINE ACETATE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- None (Tentative Approval)
- Sponsor
- AUROBINDO PHARMA LTD
- First approval
- 2023-07-31
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown